BIOLASE, Inc. (BIOL)
USD 0.02
(27.39%)
USD 0.02
(27.39%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 17.91 Million USD | 19.0% |
| 2022 | 15.05 Million USD | -0.01% |
| 2021 | 15.05 Million USD | -16.19% |
| 2020 | 17.96 Million USD | 33.37% |
| 2019 | 13.46 Million USD | 24.27% |
| 2018 | 10.83 Million USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 159 Thousand USD | 0.0% |
| 2015 | 159 Thousand USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 4.63 Million USD | 183.02% |
| 2012 | 1.63 Million USD | -37.57% |
| 2011 | 2.62 Million USD | 0.0% |
| 2010 | 2.62 Million USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 5.4 Million USD | 52.14% |
| 2007 | 3.55 Million USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 5 Million USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 2.68 Million USD | -11.02% |
| 2002 | 3.01 Million USD | 68.08% |
| 2001 | 1.79 Million USD | -40.01% |
| 2000 | 2.98 Million USD | 122.59% |
| 1999 | 1.34 Million USD | -21.06% |
| 1998 | 1.7 Million USD | 466.67% |
| 1997 | 300 Thousand USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | -100.0% |
| 1993 | 500 Thousand USD | 0.0% |
| 1992 | 500 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 17.65 Million USD | -1.42% |
| 2024 Q2 | 14.64 Million USD | -17.06% |
| 2023 Q1 | 16.09 Million USD | 6.97% |
| 2023 FY | 17.91 Million USD | 19.0% |
| 2023 Q3 | 15.1 Million USD | -6.09% |
| 2023 Q2 | 16.08 Million USD | -0.11% |
| 2023 Q4 | 17.91 Million USD | 18.59% |
| 2022 Q3 | 14.83 Million USD | -0.52% |
| 2022 Q4 | 15.05 Million USD | 1.44% |
| 2022 FY | 15.05 Million USD | -0.01% |
| 2022 Q1 | 15.86 Million USD | 5.37% |
| 2022 Q2 | 14.91 Million USD | -5.97% |
| 2021 Q1 | 18.32 Million USD | 2.01% |
| 2021 Q2 | 15.38 Million USD | -16.04% |
| 2021 FY | 15.05 Million USD | -16.19% |
| 2021 Q3 | 15.47 Million USD | 0.6% |
| 2021 Q4 | 15.05 Million USD | -2.73% |
| 2020 Q2 | 16.68 Million USD | 21.76% |
| 2020 FY | 17.96 Million USD | 33.37% |
| 2020 Q1 | 13.7 Million USD | 1.75% |
| 2020 Q3 | 18.15 Million USD | 8.84% |
| 2020 Q4 | 17.96 Million USD | -1.1% |
| 2019 Q1 | 10.9 Million USD | 0.65% |
| 2019 Q3 | 13.35 Million USD | 0.21% |
| 2019 Q4 | 13.46 Million USD | 0.82% |
| 2019 FY | 13.46 Million USD | 24.27% |
| 2019 Q2 | 13.32 Million USD | 22.21% |
| 2018 Q3 | 1.55 Million USD | 1837.5% |
| 2018 Q1 | 1.93 Million USD | 0.0% |
| 2018 FY | 10.83 Million USD | 0.0% |
| 2018 Q4 | 10.83 Million USD | 599.1% |
| 2018 Q2 | 80 Thousand USD | -95.86% |
| 2017 Q4 | - USD | -100.0% |
| 2017 FY | - USD | -100.0% |
| 2017 Q1 | 117 Thousand USD | -26.42% |
| 2017 Q2 | 74 Thousand USD | -36.75% |
| 2017 Q3 | 32 Thousand USD | -56.76% |
| 2016 FY | 159 Thousand USD | 0.0% |
| 2016 Q4 | 159 Thousand USD | 396.88% |
| 2016 Q3 | 32 Thousand USD | -86.83% |
| 2016 Q1 | 285 Thousand USD | 79.25% |
| 2016 Q2 | 243 Thousand USD | -14.74% |
| 2015 Q2 | 395 Thousand USD | 64.58% |
| 2015 Q1 | 240 Thousand USD | 0.0% |
| 2015 Q3 | 343 Thousand USD | -13.16% |
| 2015 FY | 159 Thousand USD | 0.0% |
| 2015 Q4 | 159 Thousand USD | -53.64% |
| 2014 Q2 | 3.3 Million USD | 14.8% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | 2.87 Million USD | -37.88% |
| 2014 FY | - USD | -100.0% |
| 2014 Q3 | - USD | -100.0% |
| 2013 Q3 | 5.53 Million USD | -7.64% |
| 2013 Q2 | 5.99 Million USD | 83.75% |
| 2013 Q1 | 3.26 Million USD | 99.21% |
| 2013 FY | 4.63 Million USD | 183.02% |
| 2013 Q4 | 4.63 Million USD | -16.28% |
| 2012 Q2 | 1.93 Million USD | 0.0% |
| 2012 Q4 | 1.63 Million USD | -25.22% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q3 | 2.18 Million USD | 13.13% |
| 2012 FY | 1.63 Million USD | -37.57% |
| 2011 FY | 2.62 Million USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | -100.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 Q4 | 2.62 Million USD | -9.68% |
| 2010 FY | 2.62 Million USD | 0.0% |
| 2010 Q3 | 2.9 Million USD | 0.03% |
| 2010 Q2 | 2.9 Million USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q1 | - USD | -100.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | -100.0% |
| 2008 Q2 | - USD | -100.0% |
| 2008 Q1 | 1.97 Million USD | -44.48% |
| 2008 Q4 | 5.4 Million USD | 22.54% |
| 2008 Q3 | 4.41 Million USD | 0.0% |
| 2008 FY | 5.4 Million USD | 52.14% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | 3.55 Million USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | 3.55 Million USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q2 | 5 Million USD | 0.0% |
| 2006 FY | - USD | -100.0% |
| 2006 Q3 | - USD | -100.0% |
| 2006 Q1 | 5 Million USD | 0.0% |
| 2005 Q1 | 1.85 Million USD | 0.0% |
| 2005 Q4 | 5 Million USD | 0.0% |
| 2005 FY | 5 Million USD | 0.0% |
| 2005 Q3 | 5 Million USD | 86.92% |
| 2005 Q2 | 2.67 Million USD | 44.59% |
| 2004 FY | - USD | -100.0% |
| 2004 Q1 | - USD | -100.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 FY | 2.68 Million USD | -11.02% |
| 2003 Q4 | 2.68 Million USD | -10.67% |
| 2003 Q3 | 3 Million USD | -3.97% |
| 2003 Q2 | 3.12 Million USD | 2.46% |
| 2003 Q1 | 3.04 Million USD | 1.23% |
| 2002 Q4 | 3.01 Million USD | 2.62% |
| 2002 Q3 | 2.93 Million USD | -0.37% |
| 2002 Q1 | 2.79 Million USD | 55.8% |
| 2002 FY | 3.01 Million USD | 68.08% |
| 2002 Q2 | 2.94 Million USD | 5.52% |
| 2001 Q2 | 1.79 Million USD | 0.0% |
| 2001 Q1 | 1.79 Million USD | -40.01% |
| 2001 Q4 | 1.79 Million USD | 0.0% |
| 2001 Q3 | 1.79 Million USD | 0.0% |
| 2001 FY | 1.79 Million USD | -40.01% |
| 2000 Q3 | 2.99 Million USD | 69.04% |
| 2000 Q1 | 1.76 Million USD | 31.89% |
| 2000 Q2 | 1.76 Million USD | 0.0% |
| 2000 Q4 | 2.98 Million USD | -0.16% |
| 2000 FY | 2.98 Million USD | 122.59% |
| 1999 Q3 | 1.3 Million USD | 0.0% |
| 1999 FY | 1.34 Million USD | -21.06% |
| 1999 Q4 | 1.34 Million USD | 3.23% |
| 1999 Q1 | 1.9 Million USD | 11.76% |
| 1999 Q2 | 1.3 Million USD | -31.58% |
| 1998 Q2 | 1.2 Million USD | -7.69% |
| 1998 Q1 | 1.3 Million USD | 333.33% |
| 1998 FY | 1.7 Million USD | 466.67% |
| 1998 Q3 | 1.4 Million USD | 16.67% |
| 1998 Q4 | 1.7 Million USD | 21.43% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | 300 Thousand USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | 300 Thousand USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 FY | - USD | -100.0% |
| 1994 Q3 | - USD | 0.0% |
| 1993 Q1 | 500 Thousand USD | 0.0% |
| 1993 Q2 | 1.5 Million USD | 200.0% |
| 1993 Q3 | 600 Thousand USD | -60.0% |
| 1993 FY | 500 Thousand USD | 0.0% |
| 1993 Q4 | 500 Thousand USD | -16.67% |
| 1992 Q4 | 500 Thousand USD | -28.57% |
| 1992 FY | 500 Thousand USD | 0.0% |
| 1992 Q2 | 800 Thousand USD | 0.0% |
| 1992 Q3 | 700 Thousand USD | -12.5% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 96.694% |
| Nemaura Medical Inc. | 20.03 Million USD | 10.585% |
| NeuroPace, Inc. | 72.39 Million USD | 75.261% |
| LENSAR, Inc. | 2.3 Million USD | -675.66% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -143.806% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -1022.884% |
| Apyx Medical Corporation | 38.5 Million USD | 53.482% |
| Cutera, Inc. | 431.91 Million USD | 95.853% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -14.565% |
| BioSig Technologies, Inc. | 452 Thousand USD | -3862.389% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 54.335% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 98.935% |
| Axonics, Inc. | 27.61 Million USD | 35.149% |
| IRIDEX Corporation | 2.74 Million USD | -552.221% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 77.388% |
| TELA Bio, Inc. | 42.78 Million USD | 58.135% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -4753.659% |
| RxSight, Inc. | 3.01 Million USD | -494.622% |
| Align Technology, Inc. | 96.96 Million USD | 81.53% |
| INVO Bioscience, Inc. | 8.68 Million USD | -106.252% |
| electroCore, Inc. | 626 Thousand USD | -2761.022% |
| Telesis Bio, Inc. | 34.38 Million USD | 47.906% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -74.371% |
| Quipt Home Medical Corp. | 98.94 Million USD | 81.899% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 38.32% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -662.777% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -17.404% |
| Dynatronics Corporation | 6.68 Million USD | -167.795% |
| Modular Medical, Inc. | 1.19 Million USD | -1405.042% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -6735.878% |
| Talis Biomedical Corporation | 19.66 Million USD | 8.938% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -1212.049% |
| InMode Ltd. | 9.01 Million USD | -98.625% |
| Envoy Medical, Inc. | 404 Thousand USD | -4333.168% |
| Bruker Corporation | 1.37 Billion USD | 98.702% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -31321.053% |
| DexCom, Inc. | 2.59 Billion USD | 99.31% |
| Nexalin Technology, Inc. | 4463.00 USD | -401199.574% |
| PAVmed Inc | 48.72 Million USD | 63.243% |
| Viveve Medical, Inc. | 5.34 Million USD | -234.829% |
| Cerus Corporation | 95.99 Million USD | 81.344% |
| Movano Inc. | 252 Thousand USD | -7007.143% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 46.012% |
| Nexalin Technology, Inc. | 4463.00 USD | -401199.574% |
| IceCure Medical Ltd | 599 Thousand USD | -2889.983% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 95.691% |
| enVVeno Medical Corporation | 1.4 Million USD | -1177.461% |
| 908 Devices Inc. | 5.94 Million USD | -201.262% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -28.47% |
| Orthofix Medical Inc. | 134.19 Million USD | 86.654% |
| Surmodics, Inc. | 29.4 Million USD | 39.092% |
| Nuwellis, Inc. | 981 Thousand USD | -1725.688% |
| Outset Medical, Inc. | 136.18 Million USD | 86.849% |
| Venus Concept Inc. | 79.69 Million USD | 77.527% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 86.204% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 74.525% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -113.316% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -1804.679% |
| Inogen, Inc. | 21.92 Million USD | 18.305% |
| IRadimed Corporation | 2.04 Million USD | -776.634% |
| MaxCyte, Inc. | 18.74 Million USD | 4.444% |
| Pulmonx Corporation | 41.42 Million USD | 56.764% |
| PAVmed Inc. | 48.72 Million USD | 63.243% |
| iCAD, Inc. | 461 Thousand USD | -3785.033% |
| OrthoPediatrics Corp. | 23.76 Million USD | 24.621% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -797.07% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -3540.31% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -9612.581% |
| SI-BONE, Inc. | 38.99 Million USD | 54.068% |
| Semler Scientific, Inc. | 70 Thousand USD | -25485.714% |
| Beyond Air, Inc. | 17.83 Million USD | -0.409% |
| FONAR Corporation | 41.67 Million USD | 57.025% |
| AxoGen, Inc. | 69.29 Million USD | 74.153% |
| Biotricity, Inc. | 23.87 Million USD | 24.996% |
| Cytosorbents Corporation | 18.31 Million USD | 2.201% |
| ZimVie Inc. | 521.92 Million USD | 96.569% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 64.447% |
| Inari Medical, Inc. | 32.04 Million USD | 44.113% |
| UFP Technologies, Inc. | 46.03 Million USD | 61.097% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -797.07% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -483.186% |
| Sight Sciences, Inc. | 35.41 Million USD | 49.427% |
| Insulet Corporation | 1.44 Billion USD | 98.764% |
| Profound Medical Corp. | 7.9 Million USD | -126.698% |
| Bioventus Inc. | 409.47 Million USD | 95.626% |
| InspireMD, Inc. | 1.59 Million USD | -1022.884% |
| BrainsWay Ltd. | 471 Thousand USD | -3702.548% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -1628.201% |
| Tenon Medical, Inc. | 1.17 Million USD | -1426.854% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -1687.425% |
| CVRx, Inc. | 30.61 Million USD | 41.495% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.219% |
| Sintx Technologies, Inc. | 4.24 Million USD | -321.908% |
| Acutus Medical, Inc. | 38.47 Million USD | 53.455% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -797.744% |
| NanoVibronix, Inc. | 5000.00 USD | -358100.0% |
| Quanterix Corporation | 41.46 Million USD | 56.806% |
| LivaNova PLC | 640.4 Million USD | 97.203% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -498.883% |
| Varex Imaging Corporation | 469.5 Million USD | 96.185% |
| Vivani Medical, Inc. | 20.69 Million USD | 13.462% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -662.777% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -2187.356% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 98.082% |
| TransMedics Group, Inc. | 515.94 Million USD | 96.529% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -841.146% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -7335.361% |
| Spectral AI, Inc. | 1.28 Million USD | -1289.449% |
| Hyperfine, Inc. | 185 Thousand USD | -9581.081% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 90.683% |
| Biomerica, Inc. | 785 Thousand USD | -2181.529% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -3884.578% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -4739.167% |
| Silk Road Medical, Inc | 84.63 Million USD | 78.838% |